Skip to main content

Table 5 PDAC meta-signature from the vote-counting strategy (reported consistently in at least five studies)

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

miRNA name No. of studies Mean fold-change Mean rank
Up-regulated    
hsa-miR-155 8 4.98 12.62
hsa-miR-21 7 2.95 12.29
hsa-miR-100 7 8.07 13.00
hsa-miR-221 7 6.71 11.42
hsa-miR-31 5 5.44 10.00
hsa-miR-10a 5 2.50 14.60
hsa-miR-23a 5 3.46 22.60
hsa-miR-143 5 4.03 9.40
hsa-miR-222 5 2.77 11.20
Down-regulated    
hsa-miR-217 5 18.16 4.20
hsa-miR-148a 5 8.03 7.00
hsa-miR-375 5 4.86 9.40